KVUE: Kenvue Inc. Company Short-Term Debt

Symbol and logo of brand Kenvue (KVUE)

Kenvue Inc. (KVUE) is integrating ESG principles by reducing plastic and implementing biodegradable components in production. The organization's short-term debt reflects liability dynamics, where the 1.41 mark serves as a key metric. Stable earnings are driven by consistent demand for hygiene products, while the global diversification of its brand portfolio reliably protects capital from any economic shocks.

KVUE (Kenvue Inc) Company Short-Term Debts history from 02/21/2024 to 10/30/2026

Analytical breakdowns and data insights for company Kenvue Health (KVUE)

- current quotes and average value forecast:
Price Chart Kenvue|KVUE - Fair Value Consensus
- market capitalization information:
Market Value Kenvue Inc.|KVUE - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Kenvue|KVUE - Book Capitalization|Market Cap to Net Assets Ratio kenvue.com|KVUE - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Kenvue Inc.|KVUE - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Kenvue Inc.|KVUE - Company Cumulative Indebtedness|Debts to Book Capitalization Kenvue Inc.|KVUE - Company Long-Term Loans and Borrowings|Company Short-Term Debts Kenvue|Quick Liquidity kenvue.com
- net income and valuation multiples indicators:
KVUE - Final Profit
Summary company analytics:Kenvue (KVUE)
Mass-produced product of kenvue.com

Kenvue Inc. dominance in the health products sector is reflected in its historical short-term debt data. This indicator aggregates all credit obligations due for repayment within the next twelve months. The metric assesses liquidity through the ratio of short-term borrowings to available assets. Stable cash flow from recognizable brands allows the company to manage these payments effectively. A decrease in this figure confirms high financial autonomy and capital resilience.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Short-Term Debt|Company Current Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts perrigo.com|Company Current Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Short-Term Debt|MNKD: Company Current Liabilities|amphastar.com - Amount of Current Liabilities|PCRX: Company Short-Term Debts|ARS Pharmaceuticals Inc - Company Short-Term Loans and Borrowings|TBPH (Theravance) - Company Short-Term Debts|Short-Term Debt Aquestive Corp AQST|Company Short-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Tonix Pharmaceuticals Holding Corp. TNXP|Company Short-Term Debts SXT Pharmaceuticals SXTC|Eupraxia Pharma - Company Short-Term Debts|Short-Term Debt BioHarvest Sciences Inc|eXoZymes Inc (EXOZ) - Company Short-Term Debt|Company Short-Term Indebtedness ORMP|Company Current Liabilities ENTX|Company Short-Term Debt HYFT|Company Current Liabilities ABVC (ABVC BioPharma Inc)|Company Short-Term Debts Cumberland Corp (CPIX)|Company Short-Term Debts QNTM (Quantum BioPharma Ltd)|fibrogen.com (FGEN) - Short-Term Debt|TELO: Company Current Liabilities|Company Short-Term Loans and Borrowings RANI (Rani Therapeutics)|SNYR: Company Short-Term Debts|RLYB - Short-Term Debt Volume|Company Short-Term Debt Lexaria Bioscience Corp|Company Short-Term Indebtedness PULM (pulmatrix.com)|Company Short-Term Debts PTHL|Company Current Liabilities aptorumgroup.com APM|Lyra Therapeutics, Inc - Company Current Liabilities|Short-Term Debt Volume impactbiomedinc.com (IBO)|TNFA - Company Short-Term Debt|YCBD - Company Short-Term Debts|PRFX (PainReform) - Company Current Liabilities|CYTO (Altamira Therapeutics Ltd.) - Company Short-Term Debt|Company Current Liabilities LIPO|Company Short-Term Debts OptiNose Corp|Company Short-Term Debts PIRS|PROC - Short-Term Debt|Company Short-Term Debt Petros Pharmaceuticals, Inc. PTPI|QLI (Qilian International Holding Group) - Current Liabilities|ACELYRIN, Inc. - Company Short-Term Debts|Company Short-Term Loans and Borrowings TFFP (TFF Pharmaceuticals, Inc)